Ouster exits earnings week with short sellers pulling back, a post-result dip of nearly 11%, and analysts who have not flinched — a stock that has halved its short position from the pre-print peak while still sitting on gains of roughly 16% for the month.
The earnings reaction itself is the starting point. Ouster reported on August 6, and the stock fell 3.8% the next day. Then, on August 13 — the date that had been flagged as an additional earnings event in scheduling data — the stock bounced 5.6%. The net effect heading into this week was still positive on the month. Tuesday's 10.7% drop to $42.99 is the sharpest single-session reversal in this recent run, and it has arrived just as shorts were already covering. Short interest has fallen roughly 10% over the past week to 9.8% of free float — meaningfully lower than the 11% level flagged in last week's pre-earnings note. That is a real change in positioning: shorts that built into the print have started to exit.
The borrow market is not flashing stress. Availability has actually loosened, moving from around 199% a week ago to 220% now — well above the 52-week low of 146%, meaning supply of shares to borrow remains healthy relative to demand. Cost to borrow is tracking at 0.48%, barely changed and near the bottom of the range it has occupied for months. The ORTEX short score has eased to 54.4, down from 58.4 at the peak seen on August 6 and the lowest reading in this two-week window. Taken together, the lending market is not signalling a squeeze — shorts are covering in an orderly way, not being forced out. Options confirm the lack of alarm: the put/call ratio of 0.48 is running slightly below its 20-day average of 0.51, about 1.3 standard deviations on the call-heavy side, suggesting the options market is not rushing to hedge the Tuesday selloff.
The Street remains constructive, and notably has not cracked despite the price action. All six analyst ratings are Buys or Outperforms, with a consensus mean target of $57.83 — implying roughly 34% upside from Tuesday's close. The most recent target raises came from Northland Capital Markets (to $60 in late July) and Oppenheimer (to $57 in mid-July), both lifting well ahead of the print. Rosenblatt reiterated its $53 Buy on August 7 without adjustment, a signal of steady conviction rather than enthusiasm. The bull case centres on 12.5% sequential revenue growth, record LiDAR shipments, the Stereolabs acquisition broadening the addressable market, and a $21M one-time royalty payment that flattered Q2 but did not, by the Street's reading, obscure genuine underlying progress. The bear case is harder to articulate from the analyst community — Cantor Fitzgerald downgraded to Neutral in May but the rest of the coverage has held firm.
Institutional ownership adds some texture. BlackRock added 267,000 shares to reach 7.7% of the company, reported as of July 31. State Street added 420,000 shares in the same period. Exchange Traded Concepts nearly doubled its position, adding 654,000 shares. JPMorgan Asset Management added 619,000 shares, and Renaissance Technologies added 443,000. That broad-based buying across passive and active managers through July suggests the institutional base was not anticipating the kind of dip now on display. On the insider side, the COO sold 30,000 shares on August 4 at $45 for $1.35M, and a director trimmed in the days immediately after. Those sales preceded the drop. The net insider position over 90 days is a substantial $30.8M in net sales — a persistent pattern that has been running since the June 12 coordinated sell from the CEO, CFO, CTO, COO, and General Counsel. That cluster remains the most notable signal in the insider dataset, even if each individual transaction carried low significance scores.
The stock's closest peer, AEVA, fell 11.5% on Tuesday and is down 12.6% for the week — nearly identical damage, suggesting sector-level selling rather than anything OUST-specific driving Tuesday's move. COHR dropped 12.8% on the day and FN fell 19.4%, pointing to broad pressure across photonics and sensing hardware. With the next earnings event not scheduled until November 5, the stock enters a quieter news period where the pace of short covering, whether institutional buyers add to July's positions, and whether the Tuesday selloff proves to be noise or the start of a trend reversal will all be worth tracking.
See the live data behind this article on ORTEX.
Open OUST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.